LOS ANGELES, March 3, 2023 /PRNewswire/ -- Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage biopharmaceutical company focused on precision therapies for genetically-defined cancers with alterations in mTOR pathway genes, today announced that Brendan Delaney has resigned for...
News Ticker
- [ March 20, 2023 ] Herbalife Nutrition Foundation Raises $1.5 Million at Annual Event Supporting the Nutrition Needs of Underserved Children Around the World Los Angeles Biotech News
- [ March 20, 2023 ] Online Sales Associate – Nutrum Biotech Inc. – Baldwin Park, CA Los Angeles Biotech Jobs
- [ March 20, 2023 ] Aquarium of the Pacific and Collaborators Publish New Findings About Seafood and Seaweed Farming Los Angeles Biotech News
- [ March 20, 2023 ] Sales Associate – Biotech – Selleck Chemicals LLC – Los Angeles, CA Los Angeles Biotech Jobs
- [ March 20, 2023 ] Sunrider International Hosts 2023 Women of Influence Event Los Angeles Biotech News
Copyright © 2021 Biotech Networks, LLC
